NASDAQ:BMRN
BioMarin Pharmaceutical Inc. Stock News
$81.03
-0.690 (-0.84%)
At Close: May 10, 2024
Wall Street's best-performing analysts like these 5 stocks right now - amid the market turmoil
08:03am, Sunday, 14'th Jun 2020
We used TipRanks analyst ranking service to pinpoint Wall Street's best-performing analysts.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on NuVasive (NUVA – Research Report),
Monolithic Power Systems Announces Results of the Annual Meeting of Stockholders and Second Quarter Dividend
11:34pm, Thursday, 11'th Jun 2020
Monolithic Power Systems (MPS) (Nasdaq: MPWR), a leading company in high performance analog solutions, today announced the final results of the 2020 Annual
Sangamo Stock Avoids Biotech Pitfall On Pfizer-Partnered Gene Therapy
09:14pm, Thursday, 11'th Jun 2020
Shares of Sangamo Therapeutics surged Thursday ahead of an update next week for its Pfizer-partnered gene therapy in hemophilia A. SGMO stock popped in high volume.
US Indexes Mostly Lower Again Wednesday
10:07pm, Wednesday, 10'th Jun 2020
Nasdaq reports another new high Continue reading...
Why Biomarin's Stock Is Trading Higher Today
03:03pm, Wednesday, 10'th Jun 2020
BioMarin Pharmaceutical (NASDAQ: BMRN) shares are trading higher on Wednesday, after Bank of Americamaintained its Buy rating on the stock and raised the price target from $120 to $130 per share.BioMa
B of A Securities Maintains Buy on Biomarin Pharmaceutical, Raises Price Target to $130
11:52am, Wednesday, 10'th Jun 2020Why Biomarin's Stock Is Trading Higher Today
11:03am, Wednesday, 10'th Jun 2020
BioMarin Pharmaceutical (NASDAQ: BMRN) shares are trading higher on Wednesday, after Bank of Americamaintained its Buy rating on the stock and raised the price target from $120 to $130 per share.
Jefferies 5 High-Conviction Health Care Stocks to Buy for the Second Half
07:17am, Wednesday, 10'th Jun 2020
With the first half of what has proven to be a remarkable 2020 coming to a close, many of the firms we cover across Wall Street already are looking to the second half of the year, with what should be
Hemophilia Treatment Market 2020 Industry Research, Share, Trend, Global Industry Size, Future Analysis, Regional Outlook to 2025
12:52pm, Tuesday, 09'th Jun 2020
Jun 09, 2020 (Market Insight Reports) --
Latest research report on 'Hemophilia Treatment Market' delivers a comprehensive study on current market trends. The...
The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid
12:00am, Friday, 05'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 4)
Biohaven Pharmaceutical...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs June 3)
Arena Pharmaceuticals, Inc. (...
BioMarin to Participate in Two Upcoming Virtual Investor Conferences
12:30pm, Wednesday, 03'rd Jun 2020
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer; Henry Fuchs, M.D., President, Worldwide Research & Development; and Brian
